Protocol No: RLX030A2205; An Adaptive Multicenter, Randomized, Partially Double-Blind, Placebo-Controlled Study to Assess the Safety, PK and PD/efficacy of RLX030 in Women with Pre-Eclampsia

Project: Other project

StatusFinished
Effective start/end date3/12/1212/23/14

Funding

  • Novartis Pharmaceuticals Corporation: $63,620.00